Pharma-Money

Cancer Drugs Reach All-Time High: The $100 Billion Disease that Depends on No Cure

The 2014 sales figures for cancer drugs were just published by the IMS Institute for Healthcare Informatics. Sales of cancer drugs have hit a new all-time record: $100 billion. That’s up more than 10 percent from 2013, and up from $75 billion five years earlier.

Cancer is obviously big business, as many new cancer drugs and now even cancer vaccines are in the pipe line.

Forty-five new drugs for cancer hit the market between 2010 and 2014, including 10 last year alone. These new drugs come with steep price tags, usually over $12,000.00 per month, or well over $100,000.00 per year.

An expose published by 60 Minutes [1] last year (2014) revealed that new cancer drugs are seldom more effective than older cancer drugs, with the “standard” for success being able to extend the patient’s life by 42 days.

As we have previously reported, America has lost the war on cancer. Cancer is much too big of a business now to allow anyone to cure it. Most people who fully understand this fact are heading south of the border to Mexico or over to Europe to find truly effective cancer cures that are not allowed by the FDA in the United States.

Read more